Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 161 publications
How urology can embrace the patient-centric precision focal therapy approach for localized prostate cancer.
Journal: Nature reviews. Urology
Published: March 21, 2026
Focal Cryo-ablation for Treatment of Intermediate Favorable Risk (Grade Group 2) Prostate Cancer.
Journal: Urology
Published: January 09, 2026
Evaluating indeterminate bone lesions and lymph nodes on PSMA-PET: a multidisciplinary consensus algorithm and 1-year implementation results.
Journal: European radiology
Published: September 29, 2025
Magnetic Resonance Imaging-Directed Stereotactic Body Radiation Therapy Microboost in Concert With Pelvic Nodal Irradiation for Prostate Cancer in the Higher-Risk Spectrum: Toxicity.
Journal: Advances in radiation oncology
Published: September 16, 2025
MRI performance to identify clinically significant prostate cancer following focal cryo-ablation.
Journal: BJUI compass
Published: September 10, 2025
Factors predicting sexual function dissatisfaction following primary partial gland cryoablation.
Journal: The journal of sexual medicine
Published: May 18, 2025
Routine prostate biopsies not needed after cryotherapy if surveillance MRI is normal.
Journal: BJU international
Published: May 14, 2025
Incidence, surveillance and natural history of high-grade prostatic epithelial neoplasia in the era of multiparametric MRI and targeted biopsy.
Journal: BJU international
Published: April 25, 2025
High-volume biopsy core involvement is not associated with failure after SBRT monotherapy for intermediate-risk prostate cancer.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: February 24, 2025
Implications of MRI contrast enhancement following focal prostate cancer cryoablation.
Journal: The Canadian journal of urology
Published: October 27, 2024
Functional, oncological, regret and complications following partial gland cryo-ablation for low-risk prostate cancer associated with MPMRI targets.
Journal: Urologic oncology
Published: October 11, 2024
Last Updated: 09/26/2026